The Patent Finder

Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes

Merck Sharp and Dohme LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 7 of these applications claim priority to application 61/199,179, filed Nov 13, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,415,297Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
In force
 · High confidence
Merck Sharp & Dohme LLCIn force
High confidence
US 8,592,371Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
In force
 · High confidence
Merck Sharp & Dohme LLCIn force
High confidence
US 8,772,328Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
In force
 · High confidence
Merck Sharp & Dohme LLCIn force
High confidence
US 8,951,965Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
In force
 · High confidence
Merck Sharp & Dohme LLCIn force
High confidence
US 9,138,426Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment of Diabetes
In force
 · High confidence
Merck Sharp & Dohme LLCIn force
High confidence
US 9,278,976Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment of Diabetes
In force
 · High confidence
Merck Sharp & Dohme LLCIn force
High confidence
US 9,403,790Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
In force
 · High confidence
Merck Sharp & Dohme LLCIn force
High confidence
US 8,143,289Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
In force
 · High confidence
Merck Sharp & Dohme LLCIn force
High confidence
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited